ELEVANCE HEALTH INC (ELV) Stock Institutional Trading Activity


ELEVANCE HEALTH INC (ELV) position changes reported by tracked institutional filers across multiple SEC 13F reporting periods. Based on recent SEC 13F filings (Q4 2025), investors with some of the largest reported share count changes include Brave Warrior Advisors, Eagle Capital Management, Baupost Group, Vulcan Value Partners, and Yacktman Asset Management. Explore insights into buying and selling patterns, position changes, and investment conviction levels to understand institutional trading behavior and market dynamics.

Explore more:

Portfolio quarterNameTypeQuantityRemainingReported stock balance
Q1 2025Yacktman Asset ManagementBuy435342,468$148,959,881
Q1 2025Baupost GroupBuy246,000246,000$107,000
Q1 2025Sequoia Financial AdvisorsBuy9136,717$2,921,677
Q1 2025Hancock Classic ValueBuy6,983200,980$87,418,261
Q1 2025Vulcan Value PartnersSell-15,018378,874$164,734,177
Q1 2025Sequoia FundSell-21,0331,122,920$488,425,283
Q1 2025Brave Warrior AdvisorsSell-52,4071,577,570$686,179,847
Q1 2025Eagle Capital ManagementBuy20,7321,585,348$689,562,966
Q1 2025First Eagle U.S. ValueBuy16,0223,241,361$1,409,862,551
Q4 2024Yacktman Asset ManagementSell-1,105342,033$126,175,974
Q4 2024Sequoia Financial AdvisorsSell-8615,804$2,141,082
Q4 2024Renaissance Technologies LLCBuy115,000122,973$45,364,740
Q4 2024Hancock Classic ValueBuy1,629193,997$71,565,493
Q4 2024Vulcan Value PartnersBuy114,607393,892$145,233,542
Q4 2024Sequoia FundBuy139,4201,143,953$422,004,262
Q4 2024Eagle Capital ManagementSell-35,6141,564,616$577,186,842
Q4 2024Brave Warrior AdvisorsSell-11,4361,629,977$601,298,515
Q4 2024First Eagle U.S. ValueBuy1,039,6123,225,339$1,189,827,627
Q3 2024Lountzis Asset ManagementBuy177932$484,640
Q3 2024Yacktman Asset ManagementSell-28,717343,138$178,431,760
Q3 2024Sound Shore ManagementSell-2,572119,497$62,138,440
Q3 2024Sequoia Financial AdvisorsBuy3376,665$3,465,902
Q3 2024Hancock Classic ValueBuy113192,368$100,031,360
Q3 2024Vulcan Value PartnersSell-65,653279,285$145,228,200
Q3 2024Sequoia FundSell-19,5381,004,533$522,357,160
Q3 2024Eagle Capital ManagementSell-8,2861,600,230$832,119,600
Q3 2024Brave Warrior AdvisorsBuy8,2861,641,413$853,534,760
Q3 2024First Eagle U.S. ValueBuy127,4442,185,727$1,136,578,175
Q2 2024Yacktman Asset ManagementSell-2,765371,855$201,493,350
Q2 2024Sound Shore ManagementSell-32,574122,069$66,144,309

Frequently asked questions about ELV activity

  • Which institutional owners are buying ELV?

    Institutional owners buying ELV include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.

  • What does "buy" mean in ELV activity?

    "Buy" means an investor increased their reported position in ELV compared to the prior reporting period. This reflects growing exposure to ELEVANCE HEALTH INC (ELV) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).

  • Is institutional interest in ELV increasing?

    Institutional interest in ELV can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.